Paraoxonase 1 and atrial fibrillation: Is there a relationship?-Reference-Cited by-同舟云学术

Paraoxonase 1 and atrial fibrillation: Is there a relationship?

Published:2022-11-18 Issue:46 Volume:101 Page:e31553
ISSN:1536-5964
Container-title:Medicine
language:en
Short-container-title:

Author:

Istratoaie Sabina,Boroş Bianca,Vesa Ştefan Cristian,Maria Pop Raluca,Cismaru Gabriel,Pop Dana,Vasile Milaciu Mircea,Ciumărnean Lorena,Văcăraş Vitalie,Dana Buzoianu Anca

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference28 articles.

1. Risk factor management in atrial fibrillation.;Brandes;Arrhythmia Electrophysiol Rev,2018

2. Role of inflammation and oxidative stress in atrial fibrillation.;Li;Hear Rhythm,2010

3. Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk.;Tang;Arterioscler Thromb Vasc Biol,2012

4. Validation of PON1 enzyme activity assays for longitudinal studies.;Huen;Clin Chim Acta,2009

5. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.;Aviram;J Clin Invest,1998

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Polyphenols in Modulating PON1 Activity Regarding Endothelial Dysfunction and Atherosclerosis;International Journal of Molecular Sciences;2024-03-04

2. Developing Pharmacological Therapies for Atrial Fibrillation Targeting Mitochondrial Dysfunction and Oxidative Stress: A Scoping Review;International Journal of Molecular Sciences;2023-12-30

3. Investigation of serum ischemic-modified albumin, galectin-3, paraoxonase-1, and myeloperoxidase activity levels in patients with acute brucellosis;Redox Report;2023-12-06